Dexmedetomidine
Drug0.5μg/kg Dexmedetomidine as initial loading dose is given for 15 minutes before induction of anesthesia, followed by a maintenance infusion of 0.4μg/kg/h and stopped 30 minutes before the surgery over.
NCT Number: NCT03639896
The incidence of postoperative cognitive injury is high in elderly patients, especially after major surgery. The relevant pathophysiological mechanisms are still unclear, and the possible mechanisms that have been proposed so far include inflammation, neurotransmitter imbalance and metabolic disorders. In recent years, clinical studies of acute brain dysfunction after vascular endothelial injury have attracted attention.
Degradation of the endothelial glycocalyx layer and subsequent shedding of its constituents is seen as an early marker of endothelial injury, and may increase vascular permeability.Many preclinical and clinical studies have demonstrated an association between inflammatory cytokines such as TNF-α, IL-1β, IL-6, and IL-10 and glycocalyx degradation biomarkers.
The scholars found evidence of plasma endothelial injury after abdominal open surgery in the elderly. Dexmedetomidine could attenuate stress response such as TNF-α, IL-1β and IL-6. Based on the above evidence, we hypothesize that elderly patients experience inflammatory response secondary to surgical traumatic stress after major surgery, greatly increasing the degree of endothelial injury (heparan sulphate and syndecan-1), reducing brain perfusion while increasing Blood-brain barrier permeability (S100B level), promoting the release of cytokines Interleukin-2(IL-2), Interleukin-6(IL-6), tumor necrosis factor-alpha(TNF-α) ,and vascular endothelial growth factor (VEGF) while reducing brain-derived neurotrophic factor(BDNF) synthesis, then leading to postoperative acute spasm. We would test the hypothesis that can reverse these effects and improve cognitive deficits.
Looking for future studies?
Notify Me65 year–90 year
All sexes
Interventional
Phase 4
The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
0.5μg/kg Dexmedetomidine as initial loading dose is given for 15 minutes before induction of anesthesia, followed by a maintenance infusion of 0.4μg/kg/h and stopped 30 minutes before the surgery over.
0.5μg/kg saline as initial loading dose is given for 15 minutes before induction of anesthesia, followed by a maintenance infusion of 0.4μg/kg/h and stopped 30 minutes before the surgery over.
Time frame: The 1st, 2nd and 7th day after the surgery.
Through CAM-ICU to assess the incidence of the postoperative delirium.
Time frame: 1 day Before surgery,the 3rd,7th day after the surgery.
The neuropsychological tests performed at the day before the surgery, the 3rd and 7th day after the surgery respectively.Calculate the difference(ΔX) between the score obtained before surgery and 3 or 7 days after the surgery (there are both positive and negative, we use the absolute value), with this difference( ΔX) divided by the standard deviation(SD)of the difference of the normal population, that is ΔX / SD and it is the Z score.If a patient has two or more than two of the absolute value of Z scores ≥1.96, the postoperative cognition dysfunction(POCD) is exist.
Time frame: 1 day Before surgery,the 1st, 2nd, 3rd,7th day after the surgery.
Plasma of patients was collected to test heparan sulphate and syndecan-1.
Time frame: 1 day Before surgery,the 1st, 2nd, 3rd,7th day after the surgery.
Plasma of patients was collected to test S100B level
Time frame: 1 day Before surgery,the 1st, 2nd, 3rd,7th day after the surgery.
Serum level of brain-derived neurotrophic factor (BDNF) was measured.
Time frame: 1 day Before surgery,the 1st, 2nd, 3rd,7th day after the surgery.
Plasma of patients was collected to test cytokines IL-2, IL-6, TNF-α and VEGF level.
The First Affiliated Hospital of Anhui Medical University
Other
Endothelial Injury Mechanism of Cognitive Decline and Intervention Study in Elderly Patients Undergoing Major Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03778307
Endothelial Dysfunction, Mental Disorders
Los Angeles, California, United States
View Trial DetailsNCT06472791
Endothelial Dysfunction
Portland, Oregon, United States
View Trial DetailsNCT07569744
Diabetes Mellitus, Diabetes Mellitus, Type 2
Palembang, South Sumatera, Indonesia
View Trial DetailsNCT05107869
Cardiovascular Diseases, Endothelial Dysfunction
Wauwatosa, Wisconsin, United States
View Trial Details